Published • loading... • Updated
AGILON DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Agilon Health, Inc. Investors to ...
Investors who bought agilon health securities from Feb 26 to Aug 4, 2025, may seek lead plaintiff status by March 2, 2026, in a case alleging false financial guidance.
- On Feb. 15, 2026, Rosen Law Firm issued a New York reminder that agilon health investors may move for lead plaintiff status by March 2, 2026.
- According to the complaint, defendants' statements included reckless 2025 guidance and overstated benefits from 'strategic actions,' causing investor losses, Rosen Law Firm said.
- To join the case, investors can submit an online form or contact Phillip Kim, Esq., using the provided link or toll-free number, to pursue recovery without out-of-pocket costs.
- Rosen Law Firm points to past recoveries while cautioning outcomes vary, noting investors harmed by alleged disclosures may seek damages but prior results do not guarantee outcomes.
- Citing past settlements, Rosen Law Firm encourages investors to select qualified counsel, noting many notice-issuing firms act as middlemen and may lack securities-litigation experience.
Insights by Ground AI
47 Articles
47 Articles
AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit with the ...
LOS ANGELES, Feb. 16, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. (“Agilon” or “the Company”) (NYSE: AGL ) for violations of §§10(b)…
AGILON DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AGL
NEW YORK, Feb. 15, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of agilon health,...
Coverage Details
Total News Sources47
Leaning Left6Leaning Right6Center19Last UpdatedBias Distribution61% Center
Bias Distribution
- 61% of the sources are Center
61% Center
L 20%
C 61%
R 19%
Factuality
To view factuality data please Upgrade to Premium






















